dimanche 14 juillet 2013

The Cure For Cancer Is Finally Available With Dr Stanislaw Burzynski's Targeted-Therapy Called Antineoplastons

A medical doctor and PhD Biochemist Dr Stanislaw Burzynski, discovered in 1967 a new group of small peptides in the human body.
He found that people diagnosed with cancer seemed to have low levels or lacked all together these newly discovered peptides.
He hypothesized that replenishing these peptide levels in the bodies of people with cancer - could potentially be helpful in controlling their disease.
Burzynski learned to synthesize these peptides - patented them - and called them Antineoplastons.
Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. 
Various cancer survivors are presented in the film who chose these medicines instead of surgery, chemotherapy or radiation - with full disclosure of medical records to support their diagnosis and recovery. 
When Antineoplastons are approved for public use, it will allow a single scientist to hold an exclusive right to manufacture and sell these medicines on the open market—potentially leaving the pharmaceutical industry absent in profiting from the most effective gene-targeted cancer treatment the world has ever seen.
Burzynski's victory has resulted in the American Government abandoning their initial attempt to hijack these medicines - after they filed eleven patents of an already existing Antineoplaston compound - by recruiting and colluding with one of Burzynski's own research scientists.
Now entering a new chapter, and against all odds, Antineoplastons have successfully completed a series of Food and Drud Administration (FDA) sanctioned Phase 2 clinical trials.
Dr Stanislaw Burzynski is presently the first and only scientist in United States history to enter the federal drug approval process for a proprietary cancer therapy - without any financial support from the American Government, the Pharmaceutical Industry or the Cancer Establishment.

Order your DVD now to know the full story by clicking on the picture below: